Research Determination

Print Date: 12/18/23

Title:

Rape Prevention and Education PeRPEtual (Promoting Equity in RPE Through Understanding, Action, and Leadership)

Project Id:

0900f3eb821d7e28

Accession #:

NCIPC-PPTB-8/4/23-d7e28

Project Contact:

Ishaka O Oche

Organization:

NCIPC/DVP/PPTB

Status:

Project In Progress

Intended Use:

Project Determination

Estimated Start Date:

02/01/2024

Estimated Completion Date:

01/31/2029

CDC/ATSDR HRPO/IRB Protocol #:
OMB Control #:

Determinations
Determination

Justification

Completed

Entered By & Role

8/22/23

Angel_Karen C. (idy6) CIO HSC

Not Research / Other
HSC:
Does NOT Require HRPO
Review

45 CFR 46.102(l)
Other - Continuing to enhance the capacity of state and territorial health departments

PRA:

Exclusion: Information collection not conducted or

PRA does not apply

sponsored by Federal government
Justification: NCIPC provides TA

8/22/23

Angel_Karen C. (idy6) OMB / PRA

Description & Funding
Description
Priority:

Urgent

Date Needed:

08/15/2023

Priority Justification:

Need to submit OMB clearance as soon as possible.

Determination Start Date:

08/10/23

Description:

The purpose of this NOFO is to build on the previous RPE NOFO, CDC-RFA-CE19-1902, by continuing to enhance the capacity of
state and territorial health departments (hereafter referred to as SHDs) to facilitate and monitor the implementation of sexual
violence (SV) prevention programs, practices, and policies. This five-year funding opportunity requires that recipients build
infrastructure for SV prevention; develop/enhance a state/territory action plan; implement community- and societal-level SV
prevention strategies that promote health equity; and utilize data to inform action. Completing these activities should lead to
increased capacity to promote health equity, capacity to implement/evaluate SV prevention at the community- and societal-levels,
increased partner and community awareness of effective prevention strategies, and increased partner coordination to prevent SV.
Completion of these activities should also result in increased community-level implementation of SV prevention strategies,
implementation of prevention strategies that reach high-burden communities and address social determinants of health (SDOH),
use of data to understand inequities, and monitoring and evaluation activities related to SV prevention. The activities outlined in this
NOFO will build the foundation for recipients to decrease rates of SV perpetration and victimization at the state/territory level and
reduce disparities in SV by addressing associated inequities in social and structural determinants of health.

IMS/CIO/Epi-Aid/Lab-Aid/Chemical Exposure
Submission:

No

IMS Activation Name:

Not selected

Primary Priority of the Project:

Not selected

Secondary Priority(s) of the Project:

Not selected

Task Force Associated with the Response:

Not selected

CIO Emergency Response Name:

Not selected

Epi-Aid Name:

Not selected

Lab-Aid Name:

Not selected

Assessment of Chemical Exposure Name:

Not selected

Goals/Purpose

The purpose of this NOFO, PeRPEtual, is to build upon lessons learned from CDC-RFA-CE19-1902, by encouraging the expansion
of strategies being implemented and evaluated at the community- and societal-level using a comprehensive approach across the
SEM. The PeRPEtual NOFO will seek to reduce SV victimization rates and risk factors while increasing the protective factors

associated with SV perpetration and victimization.

Objective:

Under PeRPEtual, recipients will have an opportunity to: (1) continue to build program and partner capacity to facilitate and monitor
the implementation of SV prevention programs, practices, and policies; (2) continue to support state and territorial health
departments# implementation of community-and societal-level programs, practices, and policies to prevent SV; (3) continue to
support the implementation of data-driven, comprehensive, evidence-based SV primary prevention strategies and approaches
focused particularly on health equity; and to (4) continuously conduct data to action activities to inform changes or adaptations to
existing SV strategies or on selected and implemented additional strategies.

Does your project measure health disparities among Yes
populations/groups experiencing social, economic,
geographic, and/or environmental disadvantages?:
Does your project investigate underlying
contributors to health inequities among populations
/groups experiencing social, economic, geographic,
and/or environmental disadvantages?:

Yes

Does your project propose, implement, or evaluate
an action to move towards eliminating health
inequities?:

Yes

Activities or Tasks:

New Collection of Information, Data, or Biospecimens ; Programmatic Work

Target Populations to be Included/Represented:

General US Population

Tags/Keywords:

Program Evaluation ; Violence ; Primary Prevention

CDC's Role:

Activity originated and designed by CDC staff, or conducted at the specific request of CDC, or CDC staff will approve study design
and data collection as a condition of any funding provided ; CDC employees will provide substantial technical assistance or
oversight ; CDC is providing funding

Method Categories:

Individual Interview (Quantitative); Individual Interviews (Qualitative); Survey; Technical Assistance

Methods:

Recipient's will report performance data to CDC annually using a web-based system (i.e., Partners Portal) and via virtual interviews.
No research design or human subjects involved; personally identifiable information will not be collected.

Collection of Info, Data or Biospecimen:

Information will be collected annually from funded recipients' staff through the online data system, DVP Partners Portal and through
interviews and surveys.

Expected Use of Findings/Results and their impact:

Implementation and outcomes information to be collected will provide crucial data for performance monitoring and program
evaluation of the implementation of prevention strategies and approaches, outcomes, and budget of the cooperative agreement.
Information to be collected will be used to inform technical assistance, program improvement, capacity building, and RPE Program's
impacts on SV outcomes over time. National reports that describe information across all recipients will be provided to CDC
leadership, RPE collaborators, and RPE recipients. Reports will be generated to respond to inquiries from HHS, the White House,
Congress and other partners, and these may include aggregate findings segmented or filtered by certain characteristics or
information. CDC will also generate reports specific to each recipient and provide a summary report to recipients to facilitate their
use of data for program planning and improvement. CDC will report findings to external audiences, as needed, to describe the state
of SV violence prevention across the nation; these include scientific and program conferences and meetings. Moreover, findings
and program information will be published in a peer-reviewed scientific journal to share lessons learned and findings about the RPE
Program's impact on SV prevention in the U.S.

Could Individuals potentially be identified based on
Information Collected?

No

Funding

Funding Type

Funding Title

Funding #

CDC Cooperative
Agreement

Rape Prevention and Education PeRPEtual (Promoting Equity in RPE Through
Understanding, Action, and Leadership)

CDC-RFA-CE240027

HSC Review

HSC Attributes
Other - Continuing to enhance the capacity of state
and territorial health departments

Yes

Regulation and Policy
Do you anticipate this project will need IRB review
by the CDC IRB, NIOSH IRB, or through reliance on
an external IRB?

No

Estimated number of study participants

Population - Children

Protocol Page #:

Population - Minors

Protocol Page #:

Population - Prisoners

Protocol Page #:

Original
Budget Yr

# Years
Award

Budget
Amount

2024

5

2099500.00

Population - Pregnant Women

Protocol Page #:

Population - Emancipated Minors

Protocol Page #:

Suggested level of risk to subjects
Do you anticipate this project will be exempt
research or non-exempt research

Requested consent process waviers
Informed consent for adults

No Selection

Children capable of providing assent

No Selection

Parental permission

No Selection

Alteration of authorization under HIPPA Privacy
Rule

No Selection

Requested Waivers of Documentation of Informed Consent
Informed consent for adults

No Selection

Children capable of providing assent

No Selection

Parental permission

No Selection

Consent process shown in an understandable language
Reading level has been estimated

No Selection

Comprehension tool is provided

No Selection

Short form is provided

No Selection

Translation planned or performed

No Selection

Certified translation / translator

No Selection

Translation and back-translation to/from target
language(s)

No Selection

Other method

No Selection

Clinical Trial
Involves human participants

No Selection

Assigned to an intervention

No Selection

Evaluate the effect of the intervention

No Selection

Evaluation of a health related biomedical or
behavioral outcome

No Selection

Registerable clinical trial

No Selection

Other Considerations
Exception is requested to PHS informing those
bested about HIV serostatus

No Selection

Human genetic testing is planned now or in the
future

No Selection

Involves long-term storage of identfiable biological
specimens

No Selection

Involves a drug, biologic, or device

No Selection

Conducted under an Investigational New Drug
exemption or Investigational Device Exemption

No Selection

Institutions & Staff
Institutions

Will you be working with an outside Organization or Institution? Yes
Institutions yet to be added .....

Staff
Staff
Member

SIQT
Exp. Date

Allayna
DeHond

CITI Biomedical
Exp. Date

CITI Social &
Behavioral Exp. Date

Staff Role

Email

Phone

Organization

06/26
/2026

CoInvestigator

qpi2@cdc.
gov

404-4984790

PREVENTION PRACTICE AND
TRANSLATION BRANCH

Ishaka
Oche

06/26
/2026

Project
Coordinator

phv2@cdc.
gov

404-7183558

PREVENTION PRACTICE AND
TRANSLATION BRANCH

Phillip
Williams

06/26
/2026

Program
Lead

dpz4@cdc.
gov

770-4880548

SEXUAL VIOLENCE & CAMPUS
SEXUAL VIOLENCE TEAM

05/17/2015

CITI Good Clinical
Practice Exp. Date

Data
DMP
Proposed Data Collection Start Date:

8/31/24

Proposed Data Collection End Date:

4/30/29

Proposed Public Access Level:

Non-Public

Non-Public Details:
Reason For Not Releasing Data:

Other - Program Evaluation

Public Access Justification:

We will not be sharing the raw data from the annual performance reporting. Recipient's specific summary data will be
shared only with CDC staff and the recipients. It is a small non-generalizable sample of project directors, and the data are being
used primarily to monitor and improve the program. However, we will share findings in aggregate form with other recipients,
researchers, and evaluators and public health officials to inform practice and share lessons learned. The findings will help with
program improvement and technical assistance. Data from interviews will not be used for additional analysis beyond the
summarized information that will be provided publicly through a peer-reviewed publications, factsheets and other communication
materials.

How Access Will Be Provided for Data:

These data will not be publicly released. Summarized information that will be provided publicly through a peer-reviewed
publications, factsheets and other communication materials.

Plans for Archival and Long Term Preservation:

The information collected will be stored and archived permanently for future program analysis and reporting. Data storage is
encrypted to standard requirements. The data entry interface of the DVP Partners Portal was developed using DVP-owned,
Microsoft Azure, and Platform as a Service (PaaS) cloud solution approved for use by CDC programs. All procedures have been
developed in accordance with federal, state, and local guidelines to ensure that the rights and privacy of key recipients' program
staff will be protected and maintained. While consent is not required to report aggregate data, recipient's approval will be obtained if
specific data are used for publications, reports, or other publicly disseminated information.

Spatiality

Spatiality (Geographic Locations) yet to be added .....

Dataset
Dataset

Dataset

Data Publisher

Public Access

Public Access

External

Download

Type of Data

Collection

Collection End

Title

Description

/Owner

Level

Justification

Access URL

URL

Released

Start Date

Date

Dataset yet to be added...

Supporting Info
Current

Current

CDC Staff
Member and
Role
Oche_Ishaka
(phv2)
Project Contact

Date Added

Description

Supporting Info Type

Supporting Info

08/10/2023

New RPE NOFO

Notice of Funding Opportunity

RPE PeRPEtual NOFO_CDC_RFA_CE24_0027Version
2_Leadership edits (1).docx